Skip to main content

Puerto Rico Governor Said to Name Pierluisi as Successor

Outgoing Puerto Rico Governor Ricardo Rossello will name Pedro Pierluisi, the commonwealth’s former representative in U.S. Congress, as his successor, according to an island lawmaker.

Commonwealth House Speaker Carlos “Johnny” Mendez told members that Rossello will nominate Pierluisi, Representative Jose “Quiquito” Melendez said in a telephone interview Tuesday night. The House is set to hold a special session at 1 p.m. Friday regarding the appointment of the island’s Secretary of State — next in the line of succession — according to a notice of the session.

Rossello is running out of time before he steps down Friday to name a candidate for the vacant secretary of state job who can win approval of both protesters and the island’s congress. Even though Rossello has apparently made his choice, the deal is not done: Melendez said he’s not certain whether Pierluisi’s nomination will pass the House. Pierluisi’s name is not on the notice for the chamber’s special session.

The bankrupt island is facing an unprecedented succession impasse since Rossello announced July 24 that he would step down. His decision followed massive demonstrations that started after the disclosure of leaked chats in which Rossello and aides mocked rivals and ordinary Puerto Ricans. There is no secretary of state since Luis Rivera Marin left due to his involvement in the chats. After that, the governorship would fall to Justice Secretary Wanda Vazquez, who has said she doesn’t want the job.

Michelle De La Cruz, a spokeswoman for the governor, didn’t immediately respond to requests for comment on a nomination.

Federal Board

Pierluisi, 60, is a private-practice lawyer with San Juan-based O’Neill & Borges LLC, which represents the island’s federal oversight board in Puerto Rico’s bankruptcy process. The firm’s website said he was on a leave of absence as of Tuesday. The law firm has billed the federal board at least $4,900 for time that Pierluisi specifically has spent on its cases, according to court documents.

From 2009 to 2017, Pierluisi was Puerto Rico’s non-voting member of the U.S. House, known as resident commissioner, and prior to that, he served as Puerto Rico’s justice secretary under Governor Pedro Rossello, the outgoing governor’s father. He’s a member of the ruling New Progressive Party and in the House caucused with Democrats. Pierluisi lost to Rossello in the New Progressive Party’s gubernatorial primary in 2016.

As resident commissioner, he was one of the main proponents for the approval of the Puerto Rico Oversight, Management, and Economic Stability Act of 2016, which gave Puerto Rico a path to bankruptcy court but also — controversially — installed a federal control some have called colonial overreach.

The leadership void threatens to delay Puerto Rico’s negotiations to restructure billions of dollars of debt and secure federal aid as the commonwealth recovers from 2017’s Hurricane Maria. U.S. lawmakers allocated about $42.5 billion in disaster aid, but Puerto Rico has received only about $13.6 billion, according to the federal government.

Puerto Rico’s business community wants the situation settled as soon as possible, said Jose Ledesma-Fuentes, president and board chairman of Puerto Rico’s Chamber of Commerce. Departments and agencies for economic development, housing and education need continuity, he said.

“For the benefit of the economy, we really need to know who’s going to be leading the transition efforts after he leaves,” he said. “We’re growing very frustrated with this delay.”

More must-read stories from Fortune:

—Live updates from the first night of the second Democratic debate

—These are the new rules for tonight’s Democratic debate

—Detroit happily steps into role of political HQ as Democrats gather for debate

—How to watch round two of the Democratic debates for free—even without cable

—Abortion, reparations, Israel: Topics to watch for during the second Democratic debate

—Warren-Sanders match, battle for spotlight among lesser-knowns predicted for tonight’s Democratic debate 

—Trump says he’ll be watching second Democratic debate tonight

—Biden surges in new poll ahead of second Democratic debate



from Fortune https://ift.tt/2SQwKwR
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more